DBV TECHNOLOGIES (EPA:DBV) | Finanzwire

Basculer en Français

10785	Companies
232787	Keywords
161282	Articles
124040	Press releases

Home
Companies
DBV TECHNOLOGIES

PRESS RELEASE

published on 12/16/2025 at 22:05, 7 months 13 days ago

DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
DBV Technologies reports positive Phase 3 VITESSE Trial results for VIASKIN Peanut Patch in children aged 4-7 years, meeting primary endpoint with notable treatment response rates and safety profile

Phase 3 DBV Technologies Peanut Allergy Viaskin Peanut Patch VITESSE Trial
BRIEF

published on 11/13/2025 at 17:56, 8 months 16 days ago

Artisan Partners exceeds 5% of the capital in DBV Technologies

Biopharmaceutical Shareholding Crossing Thresholds DBV Technologies Artisan Partners
BRIEF

published on 11/12/2025 at 05:55, 8 months 18 days ago

DBV Technologies: Last patient visit in the SPEED trial

Clinical Trial Phase 3 DBV Technologies Peanut Allergy Viaskin® Peanut
PRESS RELEASE

published on 11/12/2025 at 05:50, 8 months 18 days ago

DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
DBV Technologies completes last patient visit in Phase 3 VITESSE Clinical Trial of VIASKIN Peanut Patch for peanut allergic children aged 4-7 years; on track for Q4 data announcement

Clinical Trial DBV Technologies Peanut Allergy VITESSE Phase 3 Viaskin Peanut Patch
BRIEF

published on 11/04/2025 at 22:35, 8 months 25 days ago

DBV Technologies is participating in a healthcare innovation conference

DBV Technologies Viaskin Food Allergies Health Conference EPIT
PRESS RELEASE

published on 11/04/2025 at 22:30, 8 months 25 days ago

DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
DBV Technologies to participate in Guggenheim 2nd Annual Healthcare Innovation Conference with CEO Daniel Tassé at the helm, discussing treatment options for food allergies

Healthcare Innovation DBV Technologies Food Allergies VIASKIN Patch Guggenheim Conference
BRIEF

published on 10/30/2025 at 21:35, 8 months 30 days ago

DBV Technologies Appoints Philina Lee, Ph.D. to Board of Directors

Board Of Directors Biopharmaceutical DBV Technologies Viaskin Peanut Philina Lee
PRESS RELEASE

published on 10/30/2025 at 21:30, 8 months 30 days ago

DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
DBV Technologies appoints Dr. Philina Lee, Ph.D. as independent director to Board of Directors, bringing extensive biopharmaceutical experience. Company focused on VIASKIN® Peanut for food allergies

Board Of Directors DBV Technologies Food Allergies Viaskin Peanut Dr. Philina Lee
BRIEF

published on 10/28/2025 at 21:30, 9 months 1 day ago

DBV Technologies Announces Q3 2025 Financial Results

Financial Results Treasury Funding Net Loss Viaskin Peanut
PRESS RELEASE

published on 10/28/2025 at 21:25, 9 months 1 day ago

DBV Technologies Reports Third Quarter 2025 Financial Results
DBV Technologies reports Q3 2025 financial results with a cash balance of $69.8M, projecting cash runway into Q3 2026. Details on operating income, expenses, net loss, cash flow, and funding activities

Financial Results Cash Balance DBV Technologies Funding Activities Q3 2025

Accesswire

Published on 07/30/2026 at 14:00, 1 hour 19 minutes ago

Tectonic Metals Advances Investor Engagement with Leadership Appointment and Announces Equity Grants
Published on 07/30/2026 at 14:00, 1 hour 19 minutes ago

Horizon Aircraft to Participate in August Investment Conferences
Published on 07/30/2026 at 14:00, 1 hour 19 minutes ago

Rio Grande Resources Announces Market Awareness Initiative and Engages with LFG Equities Corp.
Published on 07/30/2026 at 13:50, 1 hour 29 minutes ago

Polaris Renewable Energy Announces Q2 2026 Results
Published on 07/30/2026 at 13:30, 1 hour 49 minutes ago

Alset AI Engages DS Market Solutions to Strengthen Market Liquidity and Support Shareholder Accessibility

View all ACCESSWIRE

EQS Group

Published on 07/30/2026 at 15:05, 13 minutes ago

Precisely Caps Strong First Half of 2026 with Industry Recognitions for AI Innovation, Technology Leadership, and Workplace Excellence
Published on 07/30/2026 at 15:05, 13 minutes ago

WEKA and Andromeda Partner to Power AI Workloads at Global Scale
Published on 07/30/2026 at 15:01, 17 minutes ago

Kontron AG: Mandatory tender offer acceptance period concluded - Regulatory review process pending - No majority for Ennoconn
Published on 07/30/2026 at 15:00, 19 minutes ago

Photon Energy N.V.: Invitation to Vote
Published on 07/30/2026 at 14:09, 1 hour 9 minutes ago

Diginex Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

Les Echos

Published on 07/30/2026 at 09:07, 6 hours 11 minutes ago

CNP Assicura, a subsidiary of CNP Assurances in Italy, announces an exclusive partnership with Fineco bank in the life insurance segment
Published on 07/30/2026 at 08:00, 7 hours 19 minutes ago

AMA CORP PLC: Second-quarter 2026 revenues
Published on 07/30/2026 at 07:30, 7 hours 49 minutes ago

Availability of the 2026 Interim Financial Report
Published on 07/30/2026 at 07:30, 7 hours 49 minutes ago

Half-year 2026: Accor shows its agility in a challenging global environment
Published on 07/30/2026 at 07:00, 8 hours 19 minutes ago

Mersen 2026 guidance raised after strong momentum in the first half

View all LES ECHOS COMFI WIRE